1st Quarter - Report
BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY) for BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY)
Income
—
Expenses
$83,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Issues pertaining to the FDA drug approval process and agency funding - [FY14 Agriculture, Rural Development, Food and Drug Administration and Related Agencies subcommittee bill]
| Lobbyist | Covered position, as disclosed |
|---|---|
| EMILY SHETTY New | Legislative Director, Rep. Edolphus Towns |
Health Issues HCR
Issues pertaining to access to quality care for blood cancer patients [HR 460, Patients Access to Treatments Act - all provisions]; [The Cancer Drug Coverage Parity Act - all provisions]
| Lobbyist | Covered position, as disclosed |
|---|---|
| EMILY SHETTY New | Legislative Director, Rep. Edolphus Towns |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.